Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Activation Of TLR4-MyD88 Pathway Impairs HSC Function During Acute Inflammation

Huajia Zhang, BS, Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Christen Mumaw, BS, Amy Zollman, BS, Yunlong Liu, Angelo A. Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2013) 122 (21): 2431.

https://doi.org/10.1182/blood.V122.21.2431.2431

Published: 2013

Journal Articles

Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression

Linlin Xu, Christophe Machal, Hao Wu, Bradley Poteat, Colin D. Crean, Angelo A. Cardoso, MD, PhD, John M Chirgwin, PhD, Helmut Hanenberg, MD, Khalid S. Mohammad, M.D. Ph.D., Attaya Suvannasankha, MD, Edward F Srour, PhD

Blood (2013) 122 (21): 3102.

https://doi.org/10.1182/blood.V122.21.3102.3102

Published: 2013

Journal Articles

Loss Of Canonic Notch Signaling In The Microenvironment Causes a Myeloproliferative Syndrome Via Derepression Of The miR155 Promoter

Lin Wang, PhD, Huajia Zhang, BS, Sonia Rodriguez-Rodriguez, PhD, Liyun Cao, PhD, Jonathan Parish, BS, Amy Zollman, BS, Malgorzata Kamocka, PhD, H. Scott Boswell, M.D., Edward F. Srour, Ph.D., Brahmananda Reddy Chitteti, PhD, Taghi Manshouri, Ph.D., Srdan Verstovsek, MD, PhD, Reuben Kapur, PhD, Angelo A. Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2013) 122 (21): 339.

https://doi.org/10.1182/blood.V122.21.339.339

Published: 2013

Journal Articles

STAT3 Is Required for Notch-Induced Leukemogenesis, and Functions As a Critical Survival Effector in T-Cell Leukemia

Jixin Ding, PhD, Ana L. Batista, PhD, Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Wenjun Zhang, PhD, Akira Moh, PhD, Xin-Yuan Fu, PhD, Weinian Shou, PhD, Nadia Carlesso, MD, PhD, Angelo A Cardoso, MD, PhD

Blood (2011) 118 (21): 920.

https://doi.org/10.1182/blood.V118.21.920.920

Published: 2011

Journal Articles

Activation of the Canonical Notch Signaling Pathway in the Hematopoietic Microenvironment Is Required to Maintain Normal Hematopoiesis

Lin Wang, PhD, Sonia Rodriguez-Rodriguez, PhD, Huajia Zhang, PhD student, Christen Mumaw, BS, Angelo A Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2011) 118 (21): 723.

https://doi.org/10.1182/blood.V118.21.723.723

Published: 2011

Journal Articles

Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis.

Rajasubramaniam Shanmugam, PhD., Annique Wilson-Weekes, MS, Hamid Sayar, MD, Attaya Suvannasankha, MD, Angelo A. Cardoso, MD., PhD, Katie J Sargent, RN, Larry D. Cripe, MD, Dhananjaya V Kalvakolanu, PhD., H. Scott Boswell, MD

Blood (2009) 114 (22): 2387.

https://doi.org/10.1182/blood.V114.22.2387.2387

Published: 2009

Journal Articles

Acute Lymphoblastic Leukemia Blast Cells Stimulate the Autocrine Production of CCL2 and IL-8 in Bone Marrow Stromal Cells

Jaira Ferreira de Vasconcellos, BSc, MD, Nilson Ivo Tonin Zanchin, PhD, Angelo A. Cardoso, MD., PhD, Silvia Regina Brandalise, MD, PhD, José Andrés Yunes, PhD

Blood (2008) 112 (11): 2429.

https://doi.org/10.1182/blood.V112.11.2429.2429

Published: 2008

Journal Articles

mTOR as Therapeutic Target for T-Cell Leukemia: Synergism with Conventional Cytotoxic Drugs and Signaling Inhibitors.

Ana Batista, MSc, Joao T. Barata, PhD, Lara F. Costa, Stephen E. Sallan, MD, Nadia Carlesso, MD, PhD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 521.

https://doi.org/10.1182/blood.V104.11.521.521

Published: 2004

Journal Articles

Aberrant Expression of BAFF System Molecules on B-Cell Precursor Leukemia Modulates Tumor Cell Survival: Novel Targets for Therapeutic Intervention.

Sara Maia, Sambasiva P. Rao, PhD, Stephen E. Sallan, MD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 989.

https://doi.org/10.1182/blood.V104.11.989.989

Published: 2004

Journal Articles

Crosstalk between Breast Cancer Cells and Bone Marrow Endothelium Require the Engagement of PI3K/AKT Signaling.

Joana G. Brandao, Joao T. Barata, PhD, Raquel Nunes, MD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 1299.

https://doi.org/10.1182/blood.V104.11.1299.1299

Published: 2004

NARROW

Activation Of TLR4-MyD88 Pathway Impairs HSC Function During Acute Inflammation

Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression

Loss Of Canonic Notch Signaling In The Microenvironment Causes a Myeloproliferative Syndrome Via Derepression Of The miR155 Promoter

STAT3 Is Required for Notch-Induced Leukemogenesis, and Functions As a Critical Survival Effector in T-Cell Leukemia

Activation of the Canonical Notch Signaling Pathway in the Hematopoietic Microenvironment Is Required to Maintain Normal Hematopoiesis

Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis.

Acute Lymphoblastic Leukemia Blast Cells Stimulate the Autocrine Production of CCL2 and IL-8 in Bone Marrow Stromal Cells

mTOR as Therapeutic Target for T-Cell Leukemia: Synergism with Conventional Cytotoxic Drugs and Signaling Inhibitors.

Aberrant Expression of BAFF System Molecules on B-Cell Precursor Leukemia Modulates Tumor Cell Survival: Novel Targets for Therapeutic Intervention.

Crosstalk between Breast Cancer Cells and Bone Marrow Endothelium Require the Engagement of PI3K/AKT Signaling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only